当前位置:首页 - 行情中心 - 华仁药业(300110) - 财务分析 - 现金流量表

华仁药业

(300110)

  

流通市值:39.20亿  总市值:39.25亿
流通股本:11.81亿   总股本:11.82亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,017,402,754.76658,962,409.11345,066,629.451,542,501,607.36
  收到的税费返还24,482.8124,482.817,976.52124,963.84
  收到其他与经营活动有关的现金22,773,540.1614,429,701.855,997,520.19,370,211.82
  经营活动现金流入小计1,040,200,777.73673,416,593.77351,072,126.071,551,996,783.02
  购买商品、接受劳务支付的现金385,984,593.85254,440,232.15132,865,034.41650,655,783.28
  支付给职工以及为职工支付的现金228,464,155.35146,423,853.3574,078,087.18325,678,898.38
  支付的各项税费89,055,665.662,678,512.3430,014,236.63139,019,765.48
  支付其他与经营活动有关的现金80,073,199.5540,032,339.2117,439,216.44114,282,446.22
  经营活动现金流出小计783,577,614.35503,574,937.05254,396,574.661,229,636,893.36
  经营活动产生的现金流量净额256,623,163.38169,841,656.7296,675,551.41322,359,889.66
二、投资活动产生的现金流量:
  收回投资收到的现金---57,119.62
  取得投资收益收到的现金---356,758.99
  处置固定资产、无形资产和其他长期资产收回的现金净额00-29,736
  处置子公司及其他营业单位收到的现金净额1,706,659.761,706,659.76--
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计1,706,659.761,706,659.76-443,614.61
  购建固定资产、无形资产和其他长期资产支付的现金43,063,009.3136,065,817.6825,822,417.5424,693,910.43
  取得子公司及其他营业单位支付的现金0--13,673,565.6
  投资活动现金流出小计43,063,009.3136,065,817.6825,822,417.5438,367,476.03
  投资活动产生的现金流量净额-41,356,349.55-34,359,157.92-25,822,417.54-37,923,861.42
三、筹资活动产生的现金流量:
  取得借款收到的现金470,945,250445,515,250232,105,250843,333,192.51
  收到其他与筹资活动有关的现金90,000,00090,000,000--
  筹资活动现金流入小计560,945,250535,515,250232,105,250843,333,192.51
  偿还债务支付的现金607,887,297.51523,883,192.51273,360,0001,129,122,580.46
  分配股利、利润或偿付利息支付的现金38,615,429.6923,263,526.0513,028,113.3383,263,935.21
  其中:子公司支付给少数股东的股利、利润---4,368,430.82
  支付其他与筹资活动有关的现金90,335,00090,000,000-448,822.48
  筹资活动现金流出小计736,837,727.2637,146,718.56286,388,113.331,212,835,338.15
  筹资活动产生的现金流量净额-175,892,477.2-101,631,468.56-54,282,863.33-369,502,145.64
四、汇率变动对现金及现金等价物的影响4,875.375,084.85,076.51556.98
五、现金及现金等价物净增加额39,379,21233,856,115.0416,575,347.05-85,065,560.42
  加:期初现金及现金等价物余额146,799,753.82146,799,753.82146,799,753.82231,865,314.24
  期末现金及现金等价物余额186,178,965.82180,655,868.86163,375,100.87146,799,753.82
补充资料:
  净利润-39,164,980.62--1,362,832,173.87
  资产减值准备-11,582,247.29-1,449,135,462.55
  固定资产和投资性房地产折旧-42,562,421.87-95,452,628.7
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-42,562,421.87-95,452,628.7
  无形资产摊销-11,103,453.9-22,447,672.93
  长期待摊费用摊销-4,460,281.28-8,574,611.88
  处置固定资产、无形资产和其他长期资产的损失----16,471.15
  固定资产报废损失-44,149.19-136,808.23
  财务费用-21,235,172.89-54,316,994.26
  投资损失--2,298,173.26--356,758.99
  递延所得税--3,678,118.1--18,527,557.68
  其中:递延所得税资产减少--2,154,897.46--15,152,735.78
    递延所得税负债增加--1,523,220.64--3,374,821.9
  存货的减少-38,353,357.45-9,111,247.25
  经营性应收项目的减少--31,316,744.06-172,585,288.36
  经营性应付项目的增加-38,419,574.06--108,125,784.43
  现金的期末余额-180,655,868.86-146,799,753.82
  减:现金的期初余额-146,799,753.82-231,865,314.24
  现金及现金等价物的净增加额-33,856,115.04--85,065,560.42
公告日期2025-10-302025-08-162025-04-232025-04-23
审计意见(境内)标准无保留意见
TOP↑